title: Response to Trevisson et al.
authors.affiliation: Department of Molecular Pharmacology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, California, USA.
authors.forename: Keqiang
authors.initials: K
authors.lastname: Zhang
authors.affiliation: Department of Neurosurgery, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan.
authors.forename: Jia-Wei
authors.initials: JW
authors.lastname: Lin
authors.affiliation: Institute of Injury Prevention and Control, Taipei, Taiwan.
authors.forename: Wen-Ta
authors.initials: WT
authors.lastname: Chiu
authors.affiliation: 1] Department of Molecular Pharmacology, Beckman Research Institute of the City of Hope National Medical Center, Duarte, California, USA [2] PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
authors.forename: Yun
authors.initials: Y
authors.lastname: Yen
mesh_terms: D000818:Animals; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D018095:Germ-Line Mutation; D006801:Humans; D020125:Mutation, Missense; D009442:Neurilemmoma / Q000235:genetics*; D017253:Neurofibromatoses / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*; D014451:Ubiquinone / Q000235:genetics*
chemical_list: D014451:Ubiquinone
references.citation: Clin Biochem. 2000 Jun;33(4):279-84
references.pmid: 10936586
references.citation: Genetics. 2005 Apr;169(4):1915-25
references.pmid: 15716499
references.citation: Genet Med. 2014 Oct;16(10 ):787-92
references.pmid: 24763291
references.citation: Genet Med. 2015 Apr;17(4):312-3
references.pmid: 25835193